Phase I dose-escalation and pharmacokinetic trial of lapatinib (GW572016), a selective oral dual inhibitor of ErbB-1 and -2 tyrosine kinases, in Japanese patients with solid tumors (Q46217520)
Jump to navigation
Jump to search
scientific article published on 3 December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I dose-escalation and pharmacokinetic trial of lapatinib (GW572016), a selective oral dual inhibitor of ErbB-1 and -2 tyrosine kinases, in Japanese patients with solid tumors |
scientific article published on 3 December 2008 |
Statements
1 reference
Phase I dose-escalation and pharmacokinetic trial of lapatinib (GW572016), a selective oral dual inhibitor of ErbB-1 and -2 tyrosine kinases, in Japanese patients with solid tumors (English)
1 reference
Kazuhiko Nakagawa
1 reference
Hironobu Minami
1 reference
Masayuki Kanezaki
1 reference
Akihira Mukaiyama
1 reference
Yoshiyuki Minamide
1 reference
Hisao Uejima
1 reference
Takayasu Kurata
1 reference
Toshiji Nogami
1 reference
Kenji Kawada
1 reference
Hirofumi Mukai
1 reference
Yasutsuna Sasaki
1 reference
Masahiro Fukuoka
1 reference
3 December 2008
1 reference
39
1 reference
116-123
1 reference
2
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference